MedPath

Protamine Sulfate

Protamine Sulfate Injection, USP

Approved
Approval ID

e1964129-33f4-4e4e-86e3-8e6a4e65bd83

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 17, 2023

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PROTAMINE SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-229
Application NumberANDA089454
Product Classification
M
Marketing Category
C73584
G
Generic Name
PROTAMINE SULFATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 17, 2023
FDA Product Classification

INGREDIENTS (5)

SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT
PROTAMINE SULFATEActive
Quantity: 10 mg in 1 mL
Code: 0DE9724IHC
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Protamine Sulfate - FDA Drug Approval Details